Item 1A. Risk Factors
4K characters. Original on sec.gov ·
Item 1A. Risk Factors
In addition to the other information set forth in this report and in our other reports and statements that we file with the SEC, including our quarterly reports on Form 10-Q, careful consideration should be given to the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024, which could materially affect our business, financial condition and future results. The risks described in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not presently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, operating results or cash flows.
There have been no material changes to the risk factors identified in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024.
Item 2. Unregistered Sales of Equi****ty Securities and Use of Proceeds
The following table provides information regarding our repurchases of our common stock during the third quarter of 2025:
| ISSUER PURCHASES OF EQUITY SECURITIES | ||||||||||||||||
| Total Number of Shares Purchased (1) | Average Price Paid per Share (2) | Total Number of Shares Purchased as Part of Publicly Announced Programs | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs | |||||||||||||
| July 1-31, 2025 | 406,449 | $ | 164.74 | 405,775 | $ | 1,780,352,988 | ||||||||||
| August 1-31, 2025 | 496,223 | $ | 149.42 | 495,468 | $ | 1,706,321,552 | ||||||||||
| September 1-30, 2025 | 276,948 | $ | 144.66 | 276,274 | $ | 1,666,359,408 | ||||||||||
| Total | 1,179,620 | $ | 153.58 | 1,177,517 |
(1)
Total number of shares purchased during the quarter includes 2,103 shares of our common stock surrendered by participants to satisfy tax withholding obligations in connection with the vesting of equity awards issued under our stock incentive plans.
(2)
Average price paid per share excludes a 1% excise tax imposed by the Inflation Reduction Act of 2022.
On July 28, 2021, we announced that our Board of Directors had approved a stock repurchase program authorizing us to repurchase up to an aggregate of $2.0 billion of our outstanding common stock (the “2021 Repurchase Program”). The 2021 Repurchase Program began after completion of our prior repurchase program in January 2022 and was completed in May 2024. On July 26, 2023, we announced that our Board of Directors had approved a new stock repurchase program authorizing us to repurchase up to an aggregate of $3.0 billion of our outstanding common stock (the “2023 Repurchase Program”). The 2023 Repurchase Program, which does not have an expiration date, began after the completion of the 2021 Repurchase Program in May 2024.
Under our repurchase programs, we may repurchase shares from time to time in open market purchases or through privately negotiated transactions. Shares of our common stock repurchased under our repurchase programs are canceled at the time of repurchase and are classified as authorized but unissued shares of our common stock. At September 30, 2025, we had $1.67 billion remaining authorized under the 2023 Repurchase Program.
Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information